Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

Daily cocoa extract and multivitamin/multimineral supplementation are not associated with a reduced risk for fracture among older adults.

The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains questionable.

Postmenopausal women with CSA were associated with an increased risk of developing ACPA-negative IA and progressing to RA.

Hypertension was not an independent risk factor for postoperative complications among patients undergoing surgery for pheochromocytoma.

Familial PCOS was associated with increased risks for obesity, type 2 diabetes, and hypertension among men as early as young adulthood.

Intermittent fasting yields modestly greater weight loss than daily caloric restriction among adults with overweight or obesity.

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.